PTPA and cancer: In addition, in clinical trials, phosphatase inhibitors exert a toxic effect against normal hepatic tissue [48,49,50,64], indicating that the therapeutic efficacy of PP2A inhibitors depends on precise cancer-targeted delivery systems.